scPharmaceuticals Inc. provided earnings guidance for the year of 2022. For the year, the company expected net loss to be $43 million to $48 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.14 USD | +1.97% |
|
+10.40% | -33.97% |
05-14 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.97% | 149M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- SCPH Stock
- News scPharmaceuticals Inc.
- ScPharmaceuticals Inc. Provides Earnings Guidance for the Year of 2022